tiprankstipranks
Trending News
More News >

Alan Garber Insider Profile

4 Followers
Alan Garber, Director at Exelixis, holds 6.87K shares in Vertex Pharmaceuticals (Ticker: VRTX), holds 35.70K shares in Exelixis (Ticker: EXEL).
tipranks
Alan Garber

Alan Garber
Exelixis (EXEL)
Director

Not Ranked
Alan Garber has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$5M
68.46%
31.54%
A breakdown of Alan Garber's holdings

Insider Roles

Vertex Pharmaceuticals
(VRTX)
Director
Exelixis
(EXEL)
Director
Roles that Alan Garber holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Alan Garber

Alan Garber's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Exelixis
Mar 25, 2024
Director
Uninformative Buy
459.72K
$1.57M
Vertex Pharmaceuticals
May 05, 2025
Director
Uninformative Buy
$3.41M
List of latest transactions for each holding click on a transaction to see Alan Garber's performance on stock

Alan Garber insider profile FAQ

What is the percentage of profitable transactions made by Alan Garber?
The percentage of profitable transactions made by Alan Garber is ―.
    What is the average return per transaction made by Alan Garber?
    The average return per transaction made by Alan Garber is ―.
      What stocks does Alan Garber hold?
      Alan Garber holds: EXEL, VRTX stocks.
        What was Alan Garber’s latest transaction?
        Alan Garber latest transaction was an Uninformative Buy of ―.
          What was Alan Garber's most profitable transaction?
          Alan Garber’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Alan Garber's role in Exelixis?
            Alan Garber's role in Exelixis is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.